Drug Adherence in Hypertension and Cardiovascular Protection

• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Άλλοι συγγραφείς: Burnier, Michel (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2018.
• Έκδοση: 1st ed. 2018.
• Σειρά: Updates in Hypertension and Cardiovascular Protection,
• Θέματα: Cardiology.; Pharmacotherapy.; Angiology.; Metabolic diseases.; Diabetes.; Metabolic Diseases.

This book provides a critical and comprehensive review of the methodologies available for measuring drug adherence in clinical practice, including those relying on emerging technologies. The authors discuss the risk factors of non-adherence and shed light on how to identify patients at risk of poor...

Πίνακας περιεχομένων:

• 1 Taxonomy of adherence
• I Measuring drug adherence
• 2 Qualitative assessment of adherence
• 3 Electronic monitoring of drug adherence
• 4 Measurements of drugs in plasma/urine
• 5 Assessing adherence measurement in large databases
• 6 Direct observed treatment in hypertension
• 7 Novel technologies for following drug adherence
• 8 Ethical aspects of measuring adherence II Risk factors for non-adherence
• 9 Determinants and barriers to adherence in CV diseases
• 10 Beliefs and adherence
• III Adherence in hypertension and CV protection
• 11 Impact of drug adherence in clinical trials
• 12 Drug adherence in essential hypertension: impact of drugs
• 13 Persistence in hypertension in general practice
• 14 Drug adherence in resistant hypertension
• 15 Drug adherence with cardiovascular medicines (statins)
• 16 Adherence and cardiovascular risk
• IV Interventions to improve drug adherence
• 17 Which interventions are useful?
• 18 Use of fixed-dose combinations in CV disease prevention
• 19 Nurse-led intervention in Hypertension
• 20 Role of the Pharmacist in supporting adherence
• 21 Integrated approaches to support adherence
• 22 Use of Apps to improve drug adherence
• V Health care consequences of non-adherence
• 23 Global clinical consequence of poor adherence
• 24 Cost of non-adherence.